logo-loader
THC Global Group Ltd

The Hydroponics Company Ltd granted a cannabis research licence

The licence allows Canndeo to build its exclusive Plant Breeders Rights.

The Hydroponics Company Ltd issued a cannabis research licence
Dr Andrew Beehag, CEO of Canndeo, recently presenting to investors

The Hydroponics Company (ASX:THC) is one of the first ASX-listed cannabis companies to have secured a medicinal cannabis research licence.

The license was granted to THC’s wholly owned subsidiary Canndeo Ltd by the Office of Drug Control.

The research licence will allow Canndeo to build its exclusive Plant Breeders Rights (PBR) protected Cannabis sativa strains.

Dr Andrew Beehag, chief executive officer of Canndeo, commented:

"We are very pleased to have been issued a research licence, which effectively paves the way forward for future domestic supply of medicinal cannabis, targeting multiple markets with high purity cannabidiol (CBD) and enabling THC to continue its roll out of high quality imported products as well as locally produced medicines."


Analysis

THC will now advance research into medicinal cannabis to undertake both its own research exploring optimal cultivation and production methodologies and strain development.

The company will also look to the implementation of its epigenetic technology as a key innovation in the field.

The research licence is the first step in establishing Canndeo’s domestic pharmaceutical production capability with anticipated product availability in 2018.

THC has been one of the most successful IPO's of 2017, and shares are expected to open higher today.

The heavily oversubscribed IPO was priced at $0.20 per share, with the company last trading at $0.31 per share.

Quick facts: THC Global Group Ltd

Price: $0.44

Market: ASX
Market Cap: $59.72 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

THC Global obtains manufacturing licence for Southport cannabis facility

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris talks to Proactive Investors about receiving a medicinal cannabis manufacturing licence at its large Southport manufacturing facility on Queensland's Gold Coast. The licence is required for the commercial production...

on 9/7/19

2 min read